Vanguard Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.1M | Sell |
|
|||||
|
2025
Q2 | $26.4M | Sell |
|
|||||
|
2025
Q1 | $38.6M | Sell |
|
|||||
|
2024
Q4 | $76M | Sell |
|
|||||
|
2024
Q3 | $65.3M | Buy |
|
|||||
|
2024
Q2 | $65.5M | Sell |
|
|||||
|
2024
Q1 | $80.6M | Buy |
|
|||||
|
2023
Q4 | $108M | Buy |
|
|||||
|
2023
Q3 | $61.2M | Buy |
|
|||||
|
2023
Q2 | $90.7M | Buy |
|
|||||
|
2023
Q1 | $72.5M | Buy |
|
|||||
|
2022
Q4 | $79.3M | Buy |
|
|||||
|
2022
Q3 | $113M | Buy |
|
|||||
|
2022
Q2 | $67.3M | Sell |
|
|||||
|
2022
Q1 | $68.5M | Buy |
|
|||||
|
2021
Q4 | $19.8M | Buy |
|
|||||
|
2021
Q3 | $25.6M | Buy |
|